from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1257c/-

LFCtreatmentdescriptionclass of inhibitor

0.019

Amikacinug/mL Amikacintranslation

-0.420

Cap5-10ug/mL Capreomycintranslation

0.454

Rox10-50 ug/mL Roxithromycintranslation

0.388

SM2-5 ug/mL Streptomycintranslation

-0.400

Tet5-10 ug/mL Tetracyclinetranslation

1.316

Rif0.2-5ug/mL Rifampicintranscription

0.102

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.901

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.600

CPZ10-50 ug/mL Chlorpromazinerespiration

1.594

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.157

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.128

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.144

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.441

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.687

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.013

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.953

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.089

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.830

Nigericin50 uM Nigericinrespiration

0.458

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.593

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.891

menadione6-10 ug/mL Menadionerespiration

0.377

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.381

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.258

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.173

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.514

NRP_1Non-replicating persistence stage 1dosRassociated

-0.689

Amp0.2mg/mL AmpicillincellWall

0.528

Cephalexin20-100 ug/mL CephalexincellWall

-0.431

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.102

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.046

EMB10-20 ug/mL EthambutolcellWall

-0.442

Eta12-40 ug/mL EthionamidecellWall

-0.327

INH0.2-0.4 ug/mL IsoniazidcellWall

0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.541

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

5.782

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.445

BZA0.12 mg/mL BenzamidearomaticAmides

-0.508

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.302

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.144

H2O24 mM hydrogen peroxideDNAdamaging

0.034

Levo10 ug/mL LevofloxacinDNAdamaging

-0.064

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.296

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.463

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.646

Antimycin12.5-50 ug/mL Antimycin A?

-1.162

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.035

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.563

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.163

PA8240.2-2 ug/mL PA-824?

0.529

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.557

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.401

Verapamil50 uM Verapamil?

-1.021

mercaptoethanol2 mM 2-Mercaptoethanol?

0.249

methoxatin10-20 ug/mL Methoxatin?